JHS Latest Share Price (JHS)
TODAY IN ONE LINE
With a market cap of ₹82.6 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
JHS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.08x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest JHS News
What changed recently?
Recent events, corporate actions, and announcements.
JHS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for JHS, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
JHS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for JHS — derived from the latest tape, not yesterday's close.
JHS last traded at ₹10.53 with an intraday range of ₹10.53–₹12.15 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹10.53| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 14.85 | +4.32 | +41.03% |
| R3 | 13.23 | +2.70 | +25.64% |
| R2 | 12.69 | +2.16 | +20.51% |
| R1 | 11.61 | +1.08 | +10.26% |
| PIVOT | 11.07 | 0.54 | 5.13% |
| CURRENT | 10.53 | — | — |
| S1 | 9.99 | -0.54 | -5.13% |
| S2 | 9.45 | -1.08 | -10.26% |
| S3 | 8.37 | -2.16 | -20.51% |
| S4 | 6.75 | -3.78 | -35.90% |
JHS is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹–₹
Trading Below opening range, showing Bearishness
JHS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for JHS — consolidated or standalone — with margins, YoY growth and key ratios inline.
JHS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹82.6 Cr. and reported EPS of ₹0.12.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 102 | 102 ▲ 0.0% |
| Sales Growth YoY %Derived | 10.54% | 10.54% |
| Other Income | 3 | 3 ▲ 0.0% |
| Total Income | 105 | 105 ▲ 0.0% |
| 65 | 65 ▲ 0.0% | |
| Gross ProfitDerived | 36 | 36 ▲ 0.0% |
| Gross Margin %Derived | 35.86% | 35.86% |
| 34 | 34 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 3 | 3 ▲ 0.0% |
| OPM %Derived | 2.57% | 2.57% |
| 8 | 8 ▲ 0.0% | |
| Profit Before Tax (PBT) | -2 | -2 ▲ 0.0% |
| -0 | -0 ▲ 0.0% | |
| Effective Tax %Derived | 16.07% | 16.07% |
| Total Profit for Period | -2 | -2 ▲ 0.0% |
| Less: Non-controlling Interests | — | — |
| Net Profit (Owner's PAT)Derived | -2 | -2 ▲ 0.0% |
| Net Profit Margin %Derived | -1.89% | -1.89% |
| PAT Growth YoY %Derived | 90.24% | 90.24% |
| Earnings Per Share (EPS ₹) | -0.22 | -0.22 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 9 | 9 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 107 | 107 ▲ 0.0% |
| Material Cost % of RevenueDerived | 64.21% | 64.21% |
| Employee Cost % of RevenueDerived | 11.06% | 11.06% |
| Other Cost % of RevenueDerived | 22.23% | 22.23% |
| Interest Coverage (x)Derived | -5.68x | -5.68x |
| Period | Mar 2018 | Jun 2018 | Mar 2019 | May 2019 | Mar 2020 | Jun 2020 | Mar 2021 | Jun 2021 | Mar 2022 | May 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | May 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 143 | 143 ▲ 0.0% | 124 ▼ 13.0% | 124 ▲ 0.0% | 139 ▲ 12.1% | 139 ▲ 0.0% | 101 ▼ 27.6% | 101 ▲ 0.0% | 86 ▼ 14.4% | 86 ▲ 0.0% | 96 ▲ 11.5% | 96 ▲ 0.0% | 71 ▼ 26.4% | 71 ▲ 0.0% | 92 ▲ 29.9% | 92 ▲ 0.0% | 102 ▲ 10.5% | 102 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | -12.99% | — | 12.09% | — | -27.57% | -27.57% | -14.40% | — | 11.54% | 11.54% | -26.41% | -26.41% | 29.94% | 29.94% | 10.54% | 10.54% | |
| Other Income | 5 | 5 ▲ 0.0% | 7 ▲ 33.8% | 7 ▲ 0.0% | 14 ▲ 107.6% | 14 ▲ 0.0% | 8 ▼ 45.5% | 8 ▲ 0.0% | 9 ▲ 24.5% | 9 ▲ 0.0% | 14 ▲ 53.3% | 14 ▲ 0.0% | 4 ▼ 70.0% | 4 ▲ 0.0% | 3 ▼ 33.3% | 3 ▲ 0.0% | 3 ▲ 19.9% | 3 ▲ 0.0% | |
| Total Income | 148 | 148 ▲ 0.0% | 131 ▼ 11.4% | 131 ▲ 0.0% | 153 ▲ 17.0% | 153 ▲ 0.0% | 108 ▼ 29.2% | 108 ▲ 0.0% | 96 ▼ 11.7% | 96 ▲ 0.0% | 111 ▲ 15.6% | 111 ▲ 0.0% | 75 ▼ 32.1% | 75 ▲ 0.0% | 95 ▲ 26.3% | 95 ▲ 0.0% | 105 ▲ 10.8% | 105 ▲ 0.0% | |
90 | 90 ▲ 0.0% | 87 ▼ 3.5% | 87 ▲ 0.0% | 100 ▲ 14.7% | 100 ▲ 0.0% | 68 ▼ 31.4% | 68 ▲ 0.0% | 61 ▼ 11.5% | 61 ▲ 0.0% | 66 ▲ 8.9% | 66 ▲ 0.0% | 44 ▼ 33.0% | 44 ▲ 0.0% | 61 ▲ 38.2% | 61 ▲ 0.0% | 65 ▲ 6.9% | 65 ▲ 0.0% | ||
| Gross ProfitDerived | 53 | 53 ▲ 0.0% | 37 ▼ 29.2% | 37 ▲ 0.0% | 39 ▲ 6.1% | 39 ▲ 0.0% | 32 ▼ 17.9% | 32 ▲ 0.0% | 26 ▼ 20.6% | 26 ▲ 0.0% | 30 ▲ 17.8% | 30 ▲ 0.0% | 27 ▼ 12.2% | 27 ▲ 0.0% | 31 ▲ 16.2% | 31 ▲ 0.0% | 36 ▲ 17.8% | 36 ▲ 0.0% | |
| Gross Margin %Derived | 36.85% | 36.85% | 29.98% | 29.98% | 28.38% | 28.38% | 32.18% | 32.18% | 29.85% | 29.85% | 31.54% | 31.54% | 37.63% | 37.63% | 33.65% | 33.65% | 35.86% | 35.86% | |
39 | 39 ▲ 0.0% | 38 ▼ 2.6% | 38 ▲ 0.0% | 38 ▲ 0.0% | 38 ▲ 0.0% | 31 ▼ 19.3% | 31 ▲ 0.0% | 27 ▼ 12.8% | 27 ▲ 0.0% | 39 ▲ 48.3% | 39 ▲ 0.0% | 28 ▼ 30.1% | 28 ▲ 0.0% | 35 ▲ 26.8% | 35 ▲ 0.0% | 34 ▼ 3.2% | 34 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 14 | 14 ▲ 0.0% | -1 ▼ 104.3% | -1 ▲ 0.0% | 2 ▲ 384.2% | 2 ▲ 0.0% | 2 ▲ 14.7% | 2 ▲ 0.0% | -1 ▼ 143.8% | -1 ▲ 0.0% | -9 ▼ 982.0% | -9 ▲ 0.0% | -1 ▲ 89.7% | -1 ▲ 0.0% | -4 ▼ 327.9% | -4 ▲ 0.0% | 3 ▲ 165.2% | 3 ▲ 0.0% | |
| OPM %Derived | 9.64% | 9.64% | -0.47% | -0.47% | 1.20% | 1.20% | 1.90% | 1.90% | -0.98% | -0.98% | -9.46% | -9.46% | -1.32% | -1.32% | -4.36% | -4.36% | 2.57% | 2.57% | |
35 | 35 ▲ 0.0% | 8 ▼ 76.7% | 8 ▲ 0.0% | 0 ▼ 99.1% | 0 ▲ 0.0% | 8 ▲ 11033.2% | 8 ▲ 0.0% | 8 ▼ 0.6% | 8 ▲ 0.0% | -10 ▼ 219.9% | -10 ▲ 0.0% | 7 ▲ 167.2% | 7 ▲ 0.0% | 6 ▼ 16.9% | 6 ▲ 0.0% | 8 ▲ 47.7% | 8 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 38 | 38 ▲ 0.0% | -2 ▼ 105.3% | -2 ▲ 0.0% | -6 ▼ 185.7% | -6 ▲ 0.0% | 1 ▲ 116.6% | 1 ▲ 0.0% | 0 ▼ 89.4% | 0 ▲ 0.0% | -22 ▼ 21304.3% | -22 ▲ 0.0% | -3 ▲ 84.3% | -3 ▲ 0.0% | -13 ▼ 264.8% | -13 ▲ 0.0% | -2 ▲ 81.7% | -2 ▲ 0.0% | |
12 | 12 ▲ 0.0% | -0 ▼ 103.1% | -0 ▲ 0.0% | -1 ▼ 91.7% | -1 ▲ 0.0% | 1 ▲ 229.8% | 1 ▲ 0.0% | 4 ▲ 367.5% | 4 ▲ 0.0% | -5 ▼ 215.3% | -5 ▲ 0.0% | 1 ▲ 112.4% | 1 ▲ 0.0% | 7 ▲ 1042.6% | 7 ▲ 0.0% | -0 ▼ 105.1% | -0 ▲ 0.0% | ||
| Effective Tax %Derived | 32.19% | 32.19% | 18.47% | 18.47% | 12.39% | 12.39% | 97.09% | 97.09% | 4,264.47% | 4,264.47% | 23.19% | 23.19% | -18.35% | -18.35% | -57.47% | -57.47% | 16.07% | 16.07% | |
| Total Profit for Period | 26 | 26 ▲ 0.0% | -2 ▼ 106.4% | -2 ▲ 0.0% | -5 ▼ 191.2% | -5 ▲ 0.0% | 1 ▲ 127.6% | 1 ▲ 0.0% | -4 ▼ 419.5% | -4 ▲ 0.0% | -17 ▼ 291.1% | -17 ▲ 0.0% | -4 ▲ 75.8% | -4 ▲ 0.0% | -20 ▼ 385.4% | -20 ▲ 0.0% | -2 ▲ 90.2% | -2 ▲ 0.0% | |
| Less: Non-controlling Interests | 0 | 0 ▲ 0.0% | -1 ▼ 1139.6% | -1 ▲ 0.0% | -3 ▼ 191.5% | -3 ▲ 0.0% | 0 ▲ 105.0% | 0 ▲ 0.0% | -0 ▼ 264.6% | -0 ▲ 0.0% | -1 ▼ 452.4% | -1 ▲ 0.0% | — ▲ 100.0% | — | — | — | — | — | |
| Net Profit (Owner's PAT)Derived | 26 | 26 ▲ 0.0% | -1 ▼ 102.6% | -1 ▲ 0.0% | -2 ▼ 190.7% | -2 ▲ 0.0% | 1 ▲ 160.5% | 1 ▲ 0.0% | -4 ▼ 438.2% | -4 ▲ 0.0% | -15 ▼ 281.6% | -15 ▲ 0.0% | -4 ▲ 73.8% | -4 ▲ 0.0% | -20 ▼ 385.4% | -20 ▲ 0.0% | -2 ▲ 90.2% | -2 ▲ 0.0% | |
| Net Profit Margin %Derived | 18.20% | 18.20% | -0.55% | -0.55% | -1.42% | -1.42% | 1.19% | 1.19% | -4.70% | -4.70% | -16.07% | -16.07% | -5.73% | -5.73% | -21.41% | -21.41% | -1.89% | -1.89% | |
| PAT Growth YoY %Derived | — | — | -102.62% | — | -190.74% | — | 160.54% | 160.54% | -438.17% | — | -281.64% | -281.64% | 73.76% | 73.76% | -385.40% | -385.40% | 90.24% | 90.24% | |
| Earnings Per Share (EPS ₹) | 5.87 | 5.87 ▲ 0.0% | -0.15 ▼ 102.6% | -0.15 ▲ 0.0% | -0.44 ▼ 193.3% | -0.44 ▲ 0.0% | 0.19 ▲ 143.2% | 0.19 ▲ 0.0% | -0.62 ▼ 426.3% | -0.62 ▲ 0.0% | -2.38 ▼ 283.9% | -2.38 ▲ 0.0% | -0.52 ▲ 78.2% | -0.52 ▲ 0.0% | -2.31 ▼ 344.2% | -2.31 ▲ 0.0% | -0.22 ▲ 90.5% | -0.22 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 6 ▲ 44.5% | 6 ▲ 0.0% | 6 ▲ 0.8% | 6 ▲ 0.0% | 6 ▲ 0.0% | 6 ▲ 0.0% | 8 ▲ 20.8% | 8 ▲ 0.0% | 9 ▲ 9.2% | 9 ▲ 0.0% | 9 ▲ 2.1% | 9 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 0.0% | 0 ▲ 347.1% | 0 ▲ 0.0% | 0 ▼ 52.0% | 0 ▲ 0.0% | 0 ▲ 161.1% | 0 ▲ 0.0% | 0 ▼ 10.8% | 0 ▲ 0.0% | -0 ▼ 226.2% | -0 ▲ 0.0% | 0 ▲ 146.9% | 0 ▲ 0.0% | 0 ▲ 88.8% | 0 ▲ 0.0% | 0 ▲ 27.9% | 0 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 109 | 109 ▲ 0.0% | 133 ▲ 21.6% | 133 ▲ 0.0% | 159 ▲ 19.6% | 159 ▲ 0.0% | 107 ▼ 32.4% | 107 ▲ 0.0% | 96 ▼ 11.0% | 96 ▲ 0.0% | 132 ▲ 38.6% | 132 ▲ 0.0% | 79 ▼ 40.7% | 79 ▲ 0.0% | 107 ▲ 36.7% | 107 ▲ 0.0% | 107 ▲ 0.0% | 107 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 57.59% | 57.59% | 65.84% | 65.84% | 68.26% | 68.26% | 63.54% | 63.54% | 62.24% | 62.24% | 58.25% | 58.25% | 57.65% | 57.65% | 62.46% | 62.46% | 64.21% | 64.21% | |
| Employee Cost % of RevenueDerived | 8.48% | 8.48% | 10.89% | 10.89% | 9.66% | 9.66% | 10.01% | 10.01% | 13.27% | 13.27% | 15.85% | 15.85% | 13.01% | 13.01% | 11.00% | 11.00% | 11.06% | 11.06% | |
| Other Cost % of RevenueDerived | 18.73% | 18.73% | 19.56% | 19.56% | 17.52% | 17.52% | 20.27% | 20.27% | 17.56% | 17.56% | 25.15% | 25.15% | 25.94% | 25.94% | 27.01% | 27.01% | 22.23% | 22.23% | |
| Interest Coverage (x)Derived | 9.41x | 9.41x | -7.43x | -7.43x | -3.63x | -3.63x | -4.30x | -4.30x | -5.66x | -5.66x | -15.90x | -15.90x | -15.83x | -15.83x | -21.17x | -21.17x | -5.68x | -5.68x |
JHS segment analysis : revenue and profit mix.
Disclosed business segments at JHS with their share of revenue and profit, switchable between consolidated and standalone reporting.
JHS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for JHS.
Our AI distills the core fundamental drivers supporting JHS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
JHS's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
JHS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — JHS is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
JHS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for JHS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
JHS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for JHS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in JHS stood at 53.9% of traded volume, against a 20-day average of 66.8%.
JHS announcements: results, concalls, ratings, M&A.
Filings JHS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
JHS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 74 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
JHS Svendgaard Laboratories Limited has informed the Exchange about Certificate under Regulation 74(5) SEBI (Depositories and Participants)…
Shareholders meeting
JHS Svendgaard Laboratories Limited has submitted the Exchange a copy Srutinizers report and voting results of Annual General Meeting held on…
Shareholders meeting
JHS Svendgaard Laboratories Limited has informed the Exchange about the Proceedings of 22nd Annual General Meeting of the Company.
Trading Window
JHS Svendgaard Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
General Updates
JHS Svendgaard Laboratories Limited has informed the Exchange about letter sent to shareholders whose e-mail id not registerd
JHS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue JHS has declared, sequenced by announce and record date.
JHS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About JHS: business, sector, key facts.
What JHS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
JHS operates in the Personal Care industry under the Fast Moving Consumer Goods sector, listed as NSE: JHS, BSE: 532771.
JHS Svendgaard Laboratories Limited is an Indian company primarily engaged in the manufacturing, trading, and sale of oral and dental care products for both adults and children. Their product portfolio is extensive and caters to a broad market segment.
The company's own brands include a diverse range of oral hygiene products such as toothbrushes, toothpastes, and mouthwashes. Beyond oral care, JHS also produces hand sanitizers, laundry detergents, room fresheners, and denture tablets. These products are marketed under various brand names, showcasing their strategic approach to market penetration and brand diversification. Some of their key brands include Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, and others.
A significant aspect of JHS's business model is contract manufacturing. They provide manufacturing services for other brands' oral care products, indicating a capacity for large-scale production and a strong position within the industry's supply chain. This diversified revenue stream contributes to the company's overall financial stability and resilience.
Furthermore, JHS Svendgaard Laboratories Limited extends its reach beyond the domestic Indian market through product exports. This international presence signifies a commitment to growth and expansion into global markets, enhancing brand visibility and revenue opportunities. The company's established distribution network and relationships with major retailers and pharmacies further strengthens its market position.
Founded in 1997 and headquartered in New Delhi, JHS Svendgaard Laboratories Limited has established itself as a prominent player in India's oral and dental care sector, leveraging both its own branded products and its contract manufacturing capabilities to achieve sustained growth and market share.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- BAJAJ CONSUMER CARE (BAJAJCON) Share PricePeer
- COLGATE PALMOLIVE (COLPAL) Share PricePeer
- CUPID (CUPID) Share PricePeer
- DABUR INDIA (DABUR) Share PricePeer
- EMAMI (EMAMILTD) Share PricePeer
- Top Losers TodayScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about JHS (JHS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of JHS (JHS)?
The current share price of JHS (JHS) is ₹10.53. Today, the stock has declined by ₹1.17 (10%), trading in a range of ₹10.53 to ₹12.15. The stock opened at ₹11.89 with a trading volume of 11,14,692 shares.
02What is the 52-week high and low price of JHS stock?
The 52-week high price of JHS (JHS) is ₹13.90, while the 52-week low is ₹6.26. Currently trading at ₹10.53, the stock is 68.21% above its 52-week low and 24.24% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of JHS and when is the next dividend?
JHS offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹10.53, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is JHS stock performing today in the market?
JHS stock opened at ₹11.89 and is currently trading at ₹10.53, showing a decline of ₹1.17 (10%). The intraday high is ₹12.15 and low is ₹10.53. The trading volume stands at 11,14,692 shares, indicating strong market participation today.
05What is the market capitalization of JHS?
JHS has a market capitalization of ₹82.6 Cr., making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹10.53) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of JHS?
JHS has a Return on Equity (ROE) of -1.1% and Return on Capital Employed (ROCE) of -0.77%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does JHS belong to?
JHS operates in the Fast Moving Consumer Goods sector and belongs to the Personal Care industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the debt-to-equity ratio of JHS?
JHS has a debt-to-equity ratio of 0.08, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
The data, ratios and commentary about JHS (JHS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.